{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:46:30Z","timestamp":1790934390290,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T00:00:00Z","timestamp":1170374400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s00223-006-0213-1","type":"journal-article","created":{"date-parts":[[2007,2,13]],"date-time":"2007-02-13T07:04:49Z","timestamp":1171350289000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Use of \u03b2-Blockers and the Risk of Hip\/Femur Fracture in the United Kingdom and The Netherlands"],"prefix":"10.1007","volume":"80","author":[{"given":"F.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. C.","family":"Souverein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. G. M.","family":"Leufkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. P.","family":"van Staa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,2]]},"reference":[{"key":"213_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","volume":"100","author":"P Ducy","year":"2000","unstructured":"Ducy P, Amling M, Takeda S, et al. (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197\u2013207","journal-title":"Cell"},{"key":"213_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2005.06.028","volume":"122","author":"L Fu","year":"2005","unstructured":"Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G (2005) The molecular clock mediates leptin-regulated bone formation. Cell 122:803\u2013815","journal-title":"Cell"},{"key":"213_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature03398","volume":"434","author":"F Elefteriou","year":"2005","unstructured":"Elefteriou F, Ahn JD, Takeda S, et al. (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514\u2013520","journal-title":"Nature"},{"key":"213_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","volume":"111","author":"S Takeda","year":"2002","unstructured":"Takeda S, Elefteriou F, Levasseur R, et al. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305\u2013317","journal-title":"Cell"},{"key":"213_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/434447a","volume":"434","author":"JK Elmquist","year":"2005","unstructured":"Elmquist JK, Strewler GJ (2005) Physiology: do neural signals remodel bone? Nature 434:447\u2013448","journal-title":"Nature"},{"key":"213_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/jor.1100090613","volume":"9","author":"B Minkowitz","year":"1991","unstructured":"Minkowitz B, Boskey AL, Lane JM, Pearlman HS, Vigorita VJ (1991) Effects of propranolol on bone metabolism in the rat. J Orthop Res 9:869\u2013875","journal-title":"J Orthop Res"},{"key":"213_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1359\/JBMR.0301214","volume":"19","author":"JA Pasco","year":"2004","unstructured":"Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC (2004) Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res 19:19\u201324","journal-title":"J Bone Miner Res"},{"key":"213_CR8","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"RG Schlienger","year":"2004","unstructured":"Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of beta-blockers and risk of fractures. JAMA 292:1326\u20131332","journal-title":"JAMA"},{"key":"213_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens 24:581\u2013589","journal-title":"J Hypertens"},{"key":"213_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1359\/JBMR.041202","volume":"20","author":"IR Reid","year":"2005","unstructured":"Reid IR, Gamble GD, Grey AB, et al. (2005) \u03b2-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res 20:613\u2013618","journal-title":"J Bone Miner Res"},{"key":"213_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1532-5415.2005.53178_7.x","volume":"53","author":"R Levasseur","year":"2005","unstructured":"Levasseur R, Dargent-Molina P, Sabatier JP, Marcelli C, Breart G (2005) Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l\u2019Osteoporose prospective study. J Am Geriatr Soc 53:550\u2013552","journal-title":"J Am Geriatr Soc"},{"key":"213_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00223-004-0222-x","volume":"75","author":"L Rejnmark","year":"2004","unstructured":"Rejnmark L, Vestergaard P, Kassem M, et al. (2004) Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int 75:365\u2013372","journal-title":"Calcif Tissue Int"},{"key":"213_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.blo.0000200242.52802.6d","volume":"443","author":"S Turker","year":"2006","unstructured":"Turker S, Karatosun V, Gunal I (2006) Beta-blockers increase bone mineral density. Clin Orthop Relat Res 443:73\u201374","journal-title":"Clin Orthop Relat Res"},{"key":"213_CR14","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1080\/03014460500292168","volume":"32","author":"JA Pasco","year":"2005","unstructured":"Pasco JA, Henry MJ, Nicholson GC, Schneider HG, Kotowicz MA (2005) Beta-blockers reduce bone resorption marker in early postmenopausal women. Ann Hum Biol 32:738\u2013745","journal-title":"Ann Hum Biol"},{"key":"213_CR15","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","volume":"359","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761\u20131767","journal-title":"Lancet"},{"key":"213_CR16","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","volume":"350","author":"T Walley","year":"1997","unstructured":"Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350:1097\u20131099","journal-title":"Lancet"},{"key":"213_CR17","first-page":"32","volume":"3","author":"TP Van Staa","year":"1994","unstructured":"Van Staa TP, Abenhaim L (1994) The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 3:32\u201334","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"213_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/1099-1557(200009\/10)9:5<359::AID-PDS507>3.0.CO;2-E","volume":"9","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HGM (2000) The use of a large pharmacoepidemiologic database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 9:359\u2013366","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"213_CR19","volume-title":"PHARMO A record linkage system for postmarketing surveillance of prescription drugs in The Netherlands","author":"Herings RMC","year":"1993","unstructured":"Herings RMC (1993) PHARMO A record linkage system for postmarketing surveillance of prescription drugs in The Netherlands. Utrecht, Utrecht University"},{"key":"213_CR20","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1001\/jama.285.14.1850","volume":"285","author":"TP Van Staa","year":"2001","unstructured":"Van Staa TP, Wegman S, de Vries F, Leufkens B, Cooper C (2001) Use of statins and risk of fractures. JAMA 285:1850\u20131855","journal-title":"JAMA"},{"key":"213_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1183\/09031936.05.00058204","volume":"25","author":"F De Vries","year":"2005","unstructured":"De Vries F, van Staa TP, Bracke MS, Cooper C, Leufkens HG, Lammers JW (2005) Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 25:879\u2013884","journal-title":"Eur Respir J"},{"key":"213_CR22","unstructured":"World Health Organization (2002) ATC Index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology"},{"key":"213_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00001648-199507000-00005","volume":"6","author":"S Greenland","year":"1995","unstructured":"Greenland S (1995) Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 6:356\u2013365","journal-title":"Epidemiology"},{"key":"213_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0167-4889(03)00042-9","volume":"1640","author":"M Arai","year":"2003","unstructured":"Arai M, Nagasawa T, Koshihara Y, Yamamoto S, Togari A (2003) Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochim Biophys Acta 1640:137\u2013142","journal-title":"Biochim Biophys Acta"},{"key":"213_CR25","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bone.2005.07.012","volume":"37","author":"N Bonnet","year":"2005","unstructured":"Bonnet N, Benhamou CL, Brunet-Imbault B, et al. (2005) Severe bone alterations under \u03b22 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone 37:622\u2013633","journal-title":"Bone"},{"key":"213_CR26","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1210\/jc.2005-0573","volume":"90","author":"IR Reid","year":"2005","unstructured":"Reid IR, Lucas J, Wattie D, et al. (2005) Effects of a beta-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab 90:5212\u20135216","journal-title":"J Clin Endocrinol Metab"},{"key":"213_CR27","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s00198-005-1851-2","volume":"16","author":"J Huopio","year":"2005","unstructured":"Huopio J, Honkanen R, Jurvelin J, Saarikoski S, Alhava E, Kroger H (2005) Role of chronic health disorders in perimenopausal fractures. Osteoporos Int 16:1404\u20131411","journal-title":"Osteoporos Int"},{"key":"213_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.amjhyper.2005.10.024","volume":"19","author":"A Afghani","year":"2006","unstructured":"Afghani A, Johnson CA (2006) Resting blood pressure and bone mineral content are inversely related in overweight and obese Hispanic women. Am J Hypertens 19:286\u2013292","journal-title":"Am J Hypertens"},{"key":"213_CR29","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","volume":"354","author":"FP Cappuccio","year":"1999","unstructured":"Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 354:971\u2013975","journal-title":"Lancet"},{"key":"213_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1291\/hypres.28.565","volume":"28","author":"M Gotoh","year":"2005","unstructured":"Gotoh M, Mizuno K, Ono Y, Takahashi M (2005) High blood pressure, bone-mineral loss and insulin resistance in women. Hypertens Res 28:565\u2013570","journal-title":"Hypertens Res"},{"key":"213_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1573402052952843","volume":"1","author":"JL Perez-Sactrillon","year":"2005","unstructured":"Perez-Sactrillon JL, Justo I, Sanz-Cantalapiedra A, Pueyo C, Hernadez G, Duenas A (2005) Effect of the antihypertensive treatment on the bone mineral density and osteoporotic fracture. Curr Hypertens Rev 1:61\u201366","journal-title":"Curr Hypertens Rev"},{"key":"213_CR32","unstructured":"GIP\/College voor zorgverzekeringen (2005) http:\/\/www.gipdatabank.nl\/index.asp?scherm=lijstTabelsoorten&infoType=g (accessed January 26, 2006)"},{"key":"213_CR33","first-page":"England","volume":"analysis","author":"Department","year":"2002","unstructured":"Department of Health (2002) Prescription cost analysis: England, http:\/\/www.dh.gov.uk\/PublicationsAndStatistics\/Statistics\/StatisticalWorkAreas\/StatisticalHealthCare\/StatisticalHealthCareArticle\/fs\/en?CONTENT_ID=4000027&chk=FPQDwZ (accessed October 8, 2006)","journal-title":"Prescription cost"},{"key":"213_CR34","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1136\/bmj.329.7471.868","volume":"329","author":"E Von Elm","year":"2004","unstructured":"Von Elm E, Egger M (2004) The scandal of poor epidemiological research. BMJ 329:868\u2013869","journal-title":"BMJ"},{"key":"213_CR35","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/bmj.330.7504.1342","volume":"330","author":"P Juni","year":"2005","unstructured":"Juni P, Reichenbach S, Egger M (2005) COX2 inhibitors, traditional NSAIDs, and the heart. BMJ 330:1342\u20131343","journal-title":"BMJ"},{"key":"213_CR36","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(04)16261-2","volume":"363","author":"JP Vandenbroucke","year":"2004","unstructured":"Vandenbroucke JP (2004) When are observational studies as credible as randomised trials? Lancet 363:1728\u20131731","journal-title":"Lancet"},{"key":"213_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s001980070060","volume":"11","author":"BY Farahmand","year":"2000","unstructured":"Farahmand BY, Persson PG, Michaelsson K, Baron JA, Parker MG, Ljunghall S (2000) Socioeconomic status, marital status and hip fracture risk: a population-based case-control study. Osteoporos Int 11:803\u2013808","journal-title":"Osteoporos Int"},{"key":"213_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/00001648-200111000-00017","volume":"12","author":"RJ Glynn","year":"2001","unstructured":"Glynn RJ, Knight EL, Levin R, Avorn J (2001) Paradoxical relations of drug treatment with mortality in older persons. Epidemiology 12:682\u2013689","journal-title":"Epidemiology"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-006-0213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-006-0213-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-006-0213-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-006-0213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T19:13:52Z","timestamp":1630437232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-006-0213-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1007\/s00223-006-0213-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"5 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}